European Heart Journal· 2012Q1· Review
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
- 8,522citations
- Q1SCImago
- 2012year
Short summary
These 2012 guidelines consolidate evidence for cardiovascular disease (CVD) prevention, updating recommendations for risk assessment, lifestyle interventions, and pharmacological treatments.
AI-generated from the title and abstract; the full text is not read.
Key points
- Provides updated clinical practice guidelines for cardiovascular disease prevention.
- Covers risk assessment, lifestyle modification, and pharmacological interventions.
- Developed by a joint task force representing multiple European cardiology societies.
- Aims to standardize and improve CVD prevention strategies across Europe.
AI-generated from the title and abstract; the full text is not read.
Abstract
C-reactive protein CURE Clopidogrel in Unstable Angina to Prevent Recurrent Events CVD cardiovascular disease DALYs disability-adjusted life years DBP diastolic blood
The authors' abstract, as published at the source. European Heart Journal, 2012 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Cardiology and Cardiovascular Medicine
Cardiology and Cardiovascular MedicineMedicine